Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POEM Study of metformin added to standard care for gestational diabetes mellitus
NL-OMON54531Phase 3Recruiting
- Sponsor
- Bethesda Diabetes Research Center
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of metformin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Bethesda Diabetes Research Center. Primary endpoints: GDM Outcome Score (GOS), GOS positive versus GOS negative and 3 more. Started Nov 2019; status: recruiting.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NL-OMON54531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54531.